Aim: The aim was to map and describe the university-based addiction studies programs in Africa, as part of continuing international research.
Methods: The study was conducted in 2016–2017. The first phase was based on Google and literature search of academic programs through pre-defined keywords. The second phase consisted of an in-depth analysis of characteristics of the identified programs.
The National Institute on Drug Abuse has put together information on the potential implications of this pandemic on those who struggle with substance use disorder.
This webinar is the first in a series called “Supporting People With Addiction During COVID-19”, hosted by the National Academy of Medicine and the American Society for Addiction Medicine.
Matej Kosir, Director, the Utrip Research and Development Institute (UTRIP) discusses how to successfully advocate for new university programming on drug demand reduction.
The Action Collaborative on Countering the U.S. Opioid Epidemic held a web-based listening session that focused on the perspectives and experiences of clinicians caring for patients with chronic, non-cancer pain.
This is a recording of that listening session, held on March 10, 2020.
The International Nurses Society on Addictions (IntNSA) will run its first-ever Virtual Educational Conference between October 4 through October 31.
In this presentation, Dr. Valerie Earnshaw provides a cross-cutting conceptual overview of stigma, identifies targets for stigma measurement, recommends methodological approaches for stigma research, and reviews the intervention toolkit to address stigma.
Description: Drugs of abuse target discrete collections of nerve cells—called circuits—in the brain that normally regulate responses to natural rewards in the environment, like food, sex, and social interactions. The areas of brain involved in these circuits are referred to as brain reward regions.